Speakers:
1. dr. Kartika Widayati, Sp.PD-KHOM from Gadjah Mada University, Indonesia
2. dr. Susanna Hilda Hutajulu, Ph.D., SpPD-KHOM from RSUP Dr. Sardjito, Indonesia
3. dr. Ery Kus Dwianingsih, Ph.D., Dp.PA(K) from RSU Dr. Soeradji Tirtonegoro, Indonesia
4. dr. Johan Kurnianda, Sp.PD-KHOM as Head of PERHOMPEDIN (Indonesian Medical Oncology Medical Oncology Doctors Association) Jogjakarta, Indonesia
On 18 Sep 2020, Philippines FDA approved new marketing authorization for indication locally advanced unresectable or metastatic pancreatic cancer for nimotuzumab. This…
Adelaide, South Australia (June 20, 2017) – Innokeys Pte Ltd attended ANZCHOG 2017 – a conference which is organized annually by the…
Speaker: Dr. dr. Andhika Rachman, Sp.Pd-KHOM from MRCCC Siloam Hospital Indonesia
Innokeys Pte Ltd attends Congress of Obstetrics and Gynecology Indonesia 2015 Bandung, Indonesia (Augus 26, 2015) – Innokeys Pte Ltd attended the…
New marketing authorization for indication locally advanced unresectable or metastatic pancreatic cancer is approved in Myanmar by the Myanmar FDA. This indication…
New patent is granted with the title of “Treatment of Patients Diagnosed with Pancreatic Ductal Adenocarcinoma Using Monoclonal Antibodies Against the EGFR”…